Navigation Links
OXYMATIC® 411AF Electronic Oxygen Conserver

ProductsOXYMATIC® 411AF Electronic Oxygen Conserver
Company CHAD Therapeutics, Inc.
Item OXYMATIC® 411AF Electronic Oxygen Conserver
Features 
  • Every Breath Delivery with Built-in Aluminum Body Regulator with Brass Components (Adjustable Continuous Flow)
  • Weighs approximately 1.2 lbs (544 grams) with the battery
  • Provides every-breath or alternate-breath delivery with a built-in regulator.
  • Offers 1-6 lpm flow equivalency settings to service a broad range of patients.
  • Delivers fixed pulse of oxygen within the first 200 milliseconds of inspiration.
  • Easy access to the battery compartment.
  • Description An All-In-One Conserver.

    Offers an average 5:1 increase in usage time at all settings.

    Allows the use of a standard cannula.

    The combination of the OXYMATIC conserver and lightweight cylinders offers ambulatory oxygen patients a superior alternative to liquid oxygen.

    Reliability backed by a 2-year warranty.

    NOTE: Each model has passed the ASTM PS 127-00 regulator ignition safety test.
    Info CHAD Therapeutics, Inc.
    Customer Service: (800) 423-8870
    Web site: http://www.chadtherapeutics.com

    Related medicine products :

    1. OXYMATIC® 401 Electronic Oxygen Conserver
    2. OXYMATIC® 401A Electronic Oxygen Conserver
    3. OXYMATIC® 411A Electronic Oxygen Conserver
    4. OXYMATIC® 411 Electronic Oxygen Conserver
    5. SEQUOIA OXYMATIC® 302 Electronic Oxygen Conserver
    6. SEQUOIA OXYMATIC® 312 Electronic Oxygen Conserver
    7. OXYMATIC® 2400 Electronic Oxygen Conserver
    8. SEQUOIA OXYMATIC® 311 Electronic Oxygen Conserver
    9. MaximEyes Practice Management and Electronic Medical Records Software Solutions
    10. PRAXIS® Electronic Medical Records v. 2.19
    11. MaximEyes Optometric & Ophthalmology Software for Practice Management and Electronic Medical Records
    Jewelers Forceps, delicate, straight....
    2 mm wide tip with 1 mm by 4 mm eye. Curved shaft and ring handle with polished finish....
    Straight iris forceps. Insulated....
    Hardy bayonet forceps with stops. Insulated....
    Medicine Products:
    (Date:6/26/2016)... ... 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to ... app. The fitness app plans to fix the two major problems leading the fitness industry ... fits all type program , They don’t eliminate all the reasons people quit ...
    (Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
    (Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from PsychTests.com ...
    (Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
    (Date:6/24/2016)... ... , ... People across the U.S. are sharpening their pencils and honing their ... in which patients and their families pay tribute to a genetic counselor by nominating ... of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, ...
    Breaking Medicine News(10 mins):
    (Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
    (Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
    (Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
    Breaking Medicine Technology: